USDA Develops Candidate African Swine Fever Vaccine

Jun 10, 2021

By Greg Cima

A federal research team reported progress toward creating a commercial vaccine against the devastating African swine fever virus.

An article published in May in the Journal of Virology indicates Department of Agriculture scientists at the Plum Island Animal Disease Center in New York created an attenuated vaccine candidate that can reproduce in a continuous cell line, overcoming a limitation that previous vaccine candidates required fresh macrophages from live swine. USDA Agricultural Research Service scientists had developed a previous vaccine candidate that offered effective protection, but the macrophage requirements prevented large-scale production.

Two of the article authors—USDA ARS research microbiologists Manuel Borca, PhD, and Douglas Gladue, PhD—said in a joint message that the ASF virus requires primary swine macrophages to replicate, and those macrophages do not divide. The researchers adapted an ASF virus to reproduce in a cell line that was developed at the ARS from primary porcine epithelial cells, and the attenuated vaccine candidate they produced with that modified virus protected swine as well as their previous vaccine candidate.

Click here to see more...

Video: Season 6, Episode 7: Takeaways from the Second International Conference on Pig Livability

This year’s conference fostered open, engaging conversations around current research in the swine industry, bringing together hundreds of attendees from 31 states and six countries. Two leaders who helped organize the event joined today’s episode: Dr. Joel DeRouchey, professor and swine extension specialist in the Department of Animal Sciences and Industry at Kansas State University, and Dr. Edison Magalhaes, assistant professor in the Department of Animal Sciences at Iowa State University. They share key takeaways from the conference, including the importance of integrating data when evaluating whole-herd livability, building a culture of care among employees and adopting new technologies. Above all, the discussion reinforces that this industry remains, at its core, a people business.